Luteinizing hormone-releasing hormone agonists versus orchiectomy in the treatment of prostate cancer: A systematic review

BACKGROUND: Orchiectomy has been replaced by medication represented by luteinizing hormone-releasing hormone (LHRH) agonist as the first-line therapy for androgen deprivation therapy (ADT). After the wide application of LHRH agonist, the side-effects of long-term ADT were noticed. It is time to reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xianlu, Zhang, Gejun, Wang, Jianfeng, Wang, Yanli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939757/
https://www.ncbi.nlm.nih.gov/pubmed/36814583
http://dx.doi.org/10.3389/fendo.2023.1131715

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939757/
https://www.ncbi.nlm.nih.gov/pubmed/36814583
http://dx.doi.org/10.3389/fendo.2023.1131715

Ejemplares similares